DEPRESSIVE DISORDER, MAJOR
Clinical trials for DEPRESSIVE DISORDER, MAJOR explained in plain language.
Never miss a new study
Get alerted when new DEPRESSIVE DISORDER, MAJOR trials appear
Sign up with your email to follow new studies for DEPRESSIVE DISORDER, MAJOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an arthritis drug lift depression in certain patients?
Symptom relief OngoingThis study tests whether adding the anti-inflammatory drug celecoxib to standard depression treatment can improve symptoms in people with a specific subtype called immuno-metabolic depression (IMD). IMD is marked by symptoms like increased appetite, weight gain, and fatigue, alon…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: PHASE3 • Sponsor: Amsterdam UMC, location VUmc • Aim: Symptom relief
Last updated May 17, 2026 13:57 UTC
-
Magic mushroom compound takes on depression in major trial
Symptom relief OngoingThis study tests whether a single dose of psilocybin (the active ingredient in magic mushrooms) can safely reduce depression symptoms in adults with major depressive disorder. About 238 participants will receive either 25 mg, 5 mg, or a placebo, and their mood changes will be tra…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: PHASE3 • Sponsor: Usona Institute • Aim: Symptom relief
Last updated May 17, 2026 13:56 UTC
-
Zap away depression? study of brain stimulation for tough cases pulled before start
Symptom relief TerminatedThis study aimed to see if a mild electrical brain stimulation called tDCS could help people with severe depression that didn't improve after many other treatments. Participants would have received either real or fake stimulation alongside their usual care. However, the study was…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
Brain zaps for borderline blues: new study tests rapid depression relief
Symptom relief OngoingThis study tests a fast-acting brain stimulation technique called accelerated intermittent theta-burst stimulation (aiTBS) to see if it can reduce depression in people with borderline personality disorder (BPD). Researchers will compare active stimulation to a sham (fake) treatme…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated May 14, 2026 12:01 UTC
-
Depression care gets personal: new study tests tailored treatment approach
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether choosing depression treatments based on a patient's specific symptoms and brain imaging (phenotyping) leads to better results than standard care. About 150 adults with major depression will be enrolled. The goal is to see if personalized treatment selecti…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 12, 2026 13:42 UTC
-
Suicide prevention brain zap study pulled before it began
Symptom relief TerminatedThis study aimed to see if a rapid form of brain stimulation (accelerated TMS) could reduce suicidal thinking in people hospitalized with major depression. It was designed for adults aged 22-65. However, the study was withdrawn before any participants were enrolled, so no results…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
Depression dosing study pulled before it began
Knowledge-focused TerminatedThis study planned to check if measuring sertraline levels in the blood and looking at a specific gene (CYP2C19) could help doctors give the right dose to people with major depression. It aimed to see if many patients get too much or too little medicine with standard dosing. Howe…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Sponsor: University of Belgrade • Aim: Knowledge-focused
Last updated May 17, 2026 13:56 UTC
-
Shock therapy vs. pills: which is better value for severe depression?
Knowledge-focused OngoingThis study looks at whether electroconvulsive therapy (ECT) or antidepressant medication is more cost-effective for treating severe major depression. Researchers will follow 220 adults in the Netherlands who have not gotten better with at least one antidepressant. The goal is to …
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Brain zapping study cancelled before it even started
Knowledge-focused TerminatedThis study aimed to use low-intensity focused ultrasound to temporarily change brain activity in healthy volunteers and see how it affects emotion and thinking. The goal was to learn more about how the brain works, not to treat any disease. The study was withdrawn before any part…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
Massive study digs into DNA and brain scans to personalize mental health care
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to collect DNA, brain images, and other biological samples from 2,000 people with major depression, bipolar disorder, or psychotic disorders, as well as healthy volunteers. By analyzing these samples and detailed clinical assessments, researchers hope to find phys…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated May 07, 2026 18:43 UTC